Emma Shtivelman, PhD Cancer Commons Chief Scientist
Focus: Topics:
What’s New in Immunotherapy for Non-Small Cell Lung Cancer?
Updated June 24, 2020 | Published May 25, 2020
Focus: Topics:
New Treatments For Bladder Cancer in 2020
Updated July 9, 2020 | Published March 16, 2020
Focus: Topics:
Renal Cell Cancer Treatment: The Old, the Almost Old, and the New
Updated June 24, 2020 | Published December 23, 2019
Focus: Topics:
How to Treat Uveal Melanoma that Recurs in the Liver?
Updated June 24, 2020 | Published September 9, 2019
Focus: Topics:
Why Does Exercise Guard Against Cancer? Inflammation May Play a Role
Updated June 24, 2020 | Published June 24, 2019
Focus: Topics:
Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer
Updated June 24, 2020 | Published June 24, 2019
Focus: Topics:
Regional Delivery of Mesothelin-Targeted CAR T-Cell Therapy Creates a Win for Solid Tumors
Updated June 24, 2020 | Published June 24, 2019
Focus: Topics:
FDA Expands Pembrolizumab Indication for First-Line Treatment of NSCLC (Tps ≥1%)
Updated June 24, 2020 | Published June 24, 2019
Focus: Topics:
Pembrolizumab Shows Durable Benefit as Third-Line Treatment of Advanced Small Cell Lung Cancer
Updated June 24, 2020 | Published June 24, 2019
Focus: Topics: